Pharmaceutical software company Veeva Systems has sued Microsoft in California federal court, alleging Microsoft's Viva ...

CENTRAL TRUST Co decreased its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 11.0% during the 4th ...

Veeva Systems (NYSE: VEEV) today announced that Servier will adopt Veeva RIM to unify its global regulatory operations. By ...

Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...

With Veeva RIM, Servier has a solution that enables quick adaptation to evolving EU regulatory demands. Veeva is partnering ...

DNAnexus, the leader in regulatory cloud services, today announced it will expand its relationship with Veeva to advance ...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

Hantz Financial Services Inc. lessened its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 64.8% during the 4th ...

Wells Fargo analyst Stan Berenshteyn maintained a Hold rating on Doximity (DOCS – Research Report) yesterday and set a price target of $55.00.

Leading biopharma to unify global regulatory operations on a single platform to speed submissions for new patient therapies BARCELONA, Spain, Feb. 4, 2025 /PRNewswire/ -- Veeva Systems ...

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Garty, chief technology officer, clinical data, provided his key takeaways from a panel he participated in on the growing interest ...

Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 years ago, it would be worth $7,775.33 today based on a price of $233.26 for VEEV at the time of writing.